{"id":"https://openalex.org/W2807166367","doi":"https://doi.org/10.1128/aac.00221-18","title":"Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model","display_name":"Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2807166367","doi":"https://doi.org/10.1128/aac.00221-18","mag":"2807166367","pmid":"https://pubmed.ncbi.nlm.nih.gov/29866864","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6105790"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00221-18","doi":"https://doi.org/10.1128/aac.00221-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00221-18","pdf_url":"https://aac.asm.org/content/aac/62/8/e00221-18.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/62/8/e00221-18.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036512885","display_name":"George L. Drusano","orcid":"https://orcid.org/0000-0001-9162-7332","observed_orcids":["https://orcid.org/0000-0001-9162-7332"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. L. Drusano","raw_affiliation_strings":["Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044526201","display_name":"Jenny Myrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenny Myrick","raw_affiliation_strings":["Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110824397","display_name":"Michael S. Maynard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Maynard","raw_affiliation_strings":["Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050909752","display_name":"Jocelyn Nole","orcid":"https://orcid.org/0000-0002-5263-6196","observed_orcids":["https://orcid.org/0000-0002-5263-6196"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jocelyn Nole","raw_affiliation_strings":["Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057778375","display_name":"Brandon Duncanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Duncanson","raw_affiliation_strings":["Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074271819","display_name":"David Lee Brown","orcid":"https://orcid.org/0000-0002-1778-3465","observed_orcids":["https://orcid.org/0000-0002-1778-3465"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Brown","raw_affiliation_strings":["Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062673118","display_name":"Stephan Schmidt","orcid":"https://orcid.org/0000-0002-4998-1167","observed_orcids":["https://orcid.org/0000-0002-4998-1167"]},"institutions":[{"id":"https://openalex.org/I2800717037","display_name":"University of Florida Health","ror":"https://ror.org/04tk2gy88","country_code":"US","type":"education","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephan Schmidt","raw_affiliation_strings":["Infectious Disease Pharmacokinetics Laboratory, University of Florida College of Pharmacy, Gainesville, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Pharmacokinetics Laboratory, University of Florida College of Pharmacy, Gainesville, Florida, USA","institution_ids":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026635936","display_name":"Michael Noel Neely","orcid":"https://orcid.org/0000-0002-1675-8276","observed_orcids":["https://orcid.org/0000-0002-1675-8276"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Neely","raw_affiliation_strings":["Division of Pediatric Infectious Diseases, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Infectious Diseases, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015896696","display_name":"Charles A. Scanga","orcid":"https://orcid.org/0000-0003-3654-5603","observed_orcids":["https://orcid.org/0000-0003-3654-5603"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. A. Scanga","raw_affiliation_strings":["Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055231042","display_name":"Charles A. Peloquin","orcid":"https://orcid.org/0000-0001-9002-7052","observed_orcids":["https://orcid.org/0000-0001-9002-7052"]},"institutions":[{"id":"https://openalex.org/I2800717037","display_name":"University of Florida Health","ror":"https://ror.org/04tk2gy88","country_code":"US","type":"education","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Peloquin","raw_affiliation_strings":["Infectious Disease Pharmacokinetics Laboratory, University of Florida College of Pharmacy, Gainesville, Florida, USA"],"raw_orcid":"https://orcid.org/0000-0001-9002-7052","affiliations":[{"raw_affiliation_string":"Infectious Disease Pharmacokinetics Laboratory, University of Florida College of Pharmacy, Gainesville, Florida, USA","institution_ids":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011691262","display_name":"Arnold Louie","orcid":"https://orcid.org/0000-0001-6227-7580","observed_orcids":["https://orcid.org/0000-0001-6227-7580"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arnold Louie","raw_affiliation_strings":["Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8892,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.84532435,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"62","issue":"8","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":1.0},{"id":"https://openalex.org/keywords/hollow-fiber-infection-model","display_name":"hollow-fiber infection model","score":0.7599999904632568},{"id":"https://openalex.org/keywords/oxazolidinones","display_name":"oxazolidinones","score":0.8349999785423279},{"id":"https://openalex.org/keywords/bacterial-killing","display_name":"bacterial killing","score":0.42100000381469727},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.8379999995231628},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8320000171661377},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5680000185966492},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.7289999723434448},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.3050000071525574}],"concepts":[{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.9489482641220093},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6523659825325012},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6327011585235596},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.5674851536750793},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.46991080045700073},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.45559266209602356},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44762253761291504},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44733864068984985},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4133208394050598},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3961167633533478},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37819981575012207},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3608514666557312},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32120317220687866},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.29119715094566345},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.1668848991394043},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0793396532535553},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.07876923680305481},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06305861473083496},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D015194","descriptor_name":"Diffusion Chambers, Culture","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054796","descriptor_name":"Drug Dosage Calculations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.00221-18","doi":"https://doi.org/10.1128/aac.00221-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00221-18","pdf_url":"https://aac.asm.org/content/aac/62/8/e00221-18.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5327494","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6105790","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6105790","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6105790","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:29866864","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29866864","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1128/aac.00221-18","doi":"https://doi.org/10.1128/aac.00221-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00221-18","pdf_url":"https://aac.asm.org/content/aac/62/8/e00221-18.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7349518652","display_name":"Optimizing Combination Therapy to Accelerate Clinical Cure of Tuberculosis","funder_award_id":"P01AI123036","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2807166367.pdf"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1963625941","https://openalex.org/W1964291085","https://openalex.org/W2004753123","https://openalex.org/W2019835759","https://openalex.org/W2020864288","https://openalex.org/W2042459898","https://openalex.org/W2131731929","https://openalex.org/W2134655561","https://openalex.org/W2137882841","https://openalex.org/W2148323109","https://openalex.org/W2160839923","https://openalex.org/W2161653693","https://openalex.org/W2167588734","https://openalex.org/W2242834633","https://openalex.org/W2312652920","https://openalex.org/W2408106803","https://openalex.org/W2416512300","https://openalex.org/W2543303947","https://openalex.org/W2605302163","https://openalex.org/W2969313717","https://openalex.org/W4234979152","https://openalex.org/W4289968378"],"related_works":["https://openalex.org/W7097029569","https://openalex.org/W2889641677","https://openalex.org/W1878050740","https://openalex.org/W2899026086","https://openalex.org/W2806629668","https://openalex.org/W2139097820","https://openalex.org/W1972097267","https://openalex.org/W7100074464","https://openalex.org/W2531848085","https://openalex.org/W3001687693"],"abstract_inverted_index":{"ABSTRACT":[0],"The":[1,84],"therapy":[2,19,250],"for":[3,240,247],"treatment":[4],"of":[5,26,71,114,125,155,162,172],"Mycobacterium":[6],"tuberculosis":[7,55,167,214,229,242],"infections":[8],"is":[9,21,45,232],"long":[10],"and":[11,40,64,67,93,143,164,217,243],"arduous.":[12],"It":[13],"has":[14,209,244],"been":[15],"hypothesized":[16],"that":[17,32,96,106,190,205],"the":[18,69,112,127,191,200,237,245],"duration":[20],"driven":[22],"primarily":[23],"by":[24],"populations":[25],"organisms":[27,60,95],"in":[28,61,78,215],"different":[29],"metabolic":[30,219],"states":[31],"replicate":[33],"slowly":[34],"or":[35],"not":[36,180],"at":[37],"all":[38],"(acid-phase":[39],"nonreplicative-persister":[41],"[NRP]-phase":[42],"organisms).":[43],"Linezolid":[44,133,231],"an":[46],"oxazolidinone":[47],"antimicrobial":[48],"with":[49,123,152,185],"substantial":[50,210],"activity":[51,136,211,225],"against":[52,140,212,226],"Log-phase":[53,227],"M.":[54,166,213,228,241],".":[56,230],"Here,":[57],"we":[58,110],"examined":[59],"acid-phase":[62,142,163,216],"growth":[63,66],"nonreplicative-persister-phenotype":[65],"determined":[68],"effect":[70,113],"differing":[72],"clinically":[73],"relevant":[74],"exposures":[75],"to":[76,100,177,236],"linezolid":[77,101,118,156,178,207],"a":[79,148,173,233],"hollow-fiber":[80],"infection":[81],"model":[82],"(HFIM).":[83],"endpoints":[85],"measured":[86],"were":[87,97],"bacterial":[88],"kill":[89],"over":[90,168],"29":[91,169],"days":[92],"whether":[94],"less":[98,175],"susceptible":[99,176],"could":[102],"be":[103],"recovered":[104],"during":[105],"period.":[107],"In":[108],"addition,":[109],"evaluated":[111],"administration":[115,122,124],"schedule":[116],"on":[117],"activity,":[119],"contrasting":[120],"daily":[121,128,139,157],"twice":[126],"dose":[129,150],"every":[130,186],"other":[131],"day.":[132],"demonstrated":[134,147],"robust":[135],"when":[137],"administered":[138],"both":[141],"NRP-phase":[144,165,218],"organisms.":[145],"We":[146,203],"clear":[149],"response,":[151],"900":[153],"mg":[154],"generating":[158],"\u22653":[159],"Log(CFU/ml)":[160],"killing":[161],"days.":[170],"Amplification":[171],"population":[174],"was":[179,183],"seen.":[181],"Activity":[182],"reduced":[184],"48-h":[187],"dosing,":[188],"indicating":[189],"minimum":[192],"concentration":[193],"(":[194],"C":[195],"min":[196],")/MIC":[197],"ratio":[198],"drove":[199],"microbiological":[201],"effect.":[202],"conclude":[204],"once-daily":[206],"dosing":[208],"states.":[220],"Other":[221],"studies":[222],"have":[223],"shown":[224],"valuable":[234],"addition":[235],"therapeutic":[238],"armamentarium":[239],"potential":[246],"substantially":[248],"shortening":[249],"duration.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-13T00:00:00"}